Evaluation of a new mobile system for protecting immune-suppressed patients against airborne contamination
Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient prot...
Saved in:
Published in | American journal of infection control Vol. 35; no. 7; pp. 460 - 466 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Mosby, Inc
01.09.2007
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0196-6553 1527-3296 |
DOI | 10.1016/j.ajic.2007.02.006 |
Cover
Loading…
Abstract | Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment.
Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals.
Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m
3) regardless of the levels in the room or corridor (
P < .01).
These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting. |
---|---|
AbstractList | Background Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment. Methods Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals. Results Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m3 ) regardless of the levels in the room or corridor ( P < .01). Conclusions These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting. Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment. Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals. Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m 3) regardless of the levels in the room or corridor ( P < .01). These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting. BACKGROUND: Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment. METHODS: Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals. RESULTS: Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m(3)) regardless of the levels in the room or corridor (P < .01). CONCLUSIONS: These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting. Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment. Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals. Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m(3)) regardless of the levels in the room or corridor (P < .01). These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting. Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment.BACKGROUNDInvasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment.Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals.METHODSAirborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals.Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m(3)) regardless of the levels in the room or corridor (P < .01).RESULTSFunctional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m(3)) regardless of the levels in the room or corridor (P < .01).These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting.CONCLUSIONSThese tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting. |
Author | Fischer, Alain Challier, Svetlana Malbernard, Mireille Bergeron, Vance Gangneux, Jean-Pierre Poirot, Jean-Louis Laudinet, Nicolas |
Author_xml | – sequence: 1 givenname: Jean-Louis surname: Poirot fullname: Poirot, Jean-Louis organization: Hôpital Saint-Antoine, Laboratoire de Parasitologie-Mycologie, Paris, France – sequence: 2 givenname: Jean-Pierre surname: Gangneux fullname: Gangneux, Jean-Pierre organization: Centre Hospitalier Universitaire de Rennes, Laboratoire de Parasitologie-Mycologie, Rennes, France – sequence: 3 givenname: Alain surname: Fischer fullname: Fischer, Alain organization: Hôpital Necker, Service d'Immuno-Hématologie Pédiatrique, Paris, France – sequence: 4 givenname: Mireille surname: Malbernard fullname: Malbernard, Mireille organization: Hôpital Necker, Service d'Immuno-Hématologie Pédiatrique, Paris, France – sequence: 5 givenname: Svetlana surname: Challier fullname: Challier, Svetlana organization: Laboratoire de Microbiologie, Paris, France – sequence: 6 givenname: Nicolas surname: Laudinet fullname: Laudinet, Nicolas organization: irInSpace SAS, Montigny-le-Bretonneux, France – sequence: 7 givenname: Vance surname: Bergeron fullname: Bergeron, Vance email: vance.bergeron@ens-lyon.fr organization: Ecole Normale Supérieure de Lyon, Laboratoire de Physique CNRS UMR 5672, Lyon, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17765558$$D View this record in MEDLINE/PubMed https://hal.science/hal-00690447$$DView record in HAL |
BookMark | eNqFkl-L1DAUxYOsuLOjX8AHyZPgQ8ebtE1bEWFZ9o8w4IP6HNL0dk1tkzFJR-bbm-6sCguuT4HL-Z0k59wzcmKdRUJeMtgwYOLtsFGD0RsOUG2AbwDEE7JiJa-ynDfihKyANSITZZmfkrMQBgBoclE-I6esqtK4rFdkuNyrcVbROEtdTxW1-JNOrjUj0nAIESfaO0933kXU0dhbaqZptpiFebfzGAJ2dJdwtDFQdauMDZEq41vnLVLtbFSTsXf-z8nTXo0BX9yfa_L16vLLxU22_XT98eJ8m-miKWKmsevyHGohEHWnlaoE53VZFApyhhyU7usWWKn7qhVcVFqXGjhri04p7FqWr8mbo-83NcqdN5PyB-mUkTfnW7nMUlANFEW1X7Svj9r0wR8zhignEzSOo7Lo5iBFzXlZpwTX5NW9cG4n7P74_k4yCfhRoL0LwWP_VwJyqUsOcqlLLnVJ4MsrElQ_gLSJd2FFr8z4OPr-iGKKcm_Qy6BTCyk941NTsnPmcfzDA1yPxhqtxu94wDC42dtUkmQyJEB-XlZp2SSoAArRLIG8-7fB_27_BXZ92ms |
CitedBy_id | crossref_primary_10_1016_j_jhin_2022_06_013 crossref_primary_10_1016_S1773_035X_08_73334_3 crossref_primary_10_1016_j_ajic_2009_09_014 crossref_primary_10_1016_j_buildenv_2020_106643 crossref_primary_10_1016_j_ajic_2008_12_006 crossref_primary_10_1017_ice_2016_81 crossref_primary_10_1016_j_jhin_2022_02_002 crossref_primary_10_1016_j_jhin_2025_02_015 crossref_primary_10_3109_13693786_2011_575890 crossref_primary_10_1016_j_jhin_2010_08_012 crossref_primary_10_1007_s12553_020_00480_z crossref_primary_10_1016_j_jhin_2008_03_018 crossref_primary_10_1016_j_jopr_2013_01_013 crossref_primary_10_1017_ice_2017_18 |
Cites_doi | 10.1086/647679 10.1086/647317 10.1086/377537 10.1086/501661 10.1086/341318 10.1097/00006454-199808000-00011 10.1078/1438-4639-00054 10.1053/jhin.2001.0998 10.1053/jhin.2002.1308 10.1017/S0195941700067114 10.1016/0002-9343(87)90902-8 10.1111/j.1399-3062.2004.00047.x 10.1080/15428119791012252 10.1016/j.jhin.2005.03.004 10.1016/S0195-6701(98)90326-7 10.1007/s10295-005-0226-1 |
ContentType | Journal Article |
Copyright | 2007 Association for Professionals in Infection Control and Epidemiology, Inc. Association for Professionals in Infection Control and Epidemiology, Inc. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: 2007 Association for Professionals in Infection Control and Epidemiology, Inc. – notice: Association for Professionals in Infection Control and Epidemiology, Inc. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC |
DOI | 10.1016/j.ajic.2007.02.006 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1527-3296 |
EndPage | 466 |
ExternalDocumentID | oai_HAL_hal_00690447v1 17765558 10_1016_j_ajic_2007_02_006 S0196655307004695 1_s2_0_S0196655307004695 |
Genre | Evaluation Studies Journal Article |
GeographicLocations | France |
GeographicLocations_xml | – name: France |
GroupedDBID | --- --K --M ..I .1- .FO .GJ .~1 0-6 0R~ 1B1 1P~ 1RT 1Z5 1~. 1~5 23M 2KS 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AAAJQ AABNK AABSN AAEDT AAEDW AAIKC AAIKJ AAKOC AALRI AAMNW AAOAW AAQFI AAQXK AARKO AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACJTP ACRLP ACRPL ACVFH ACXZT ADBBV ADCNI ADEZE ADIMB ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXBA AFXIZ AGBRE AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BEEDS BKOJK BLXMC BNPGV C45 CAG CJTIS COF COPKO CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FAFAN FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEJ HMK HMO HVGLF HZ~ H~W IH2 IHE J1W J5H K-O KOM L7B LUGTX M27 M41 MO0 N4W N9A O-L O9- OAUVE OD- OEN OMK ONC ONOOK OO. OUGNH OVD OZT P-8 P-9 PC. PQQKQ Q38 R2- ROL RPZ SAE SDF SDG SDP SEL SES SEW SNC SND SNG SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UHS UV1 WH7 WOQ WOW WUQ XCE YFH YOC Z5R ZGI ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AISVY AJBFU EFLBG LCYCR NAHTW ZA5 AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC |
ID | FETCH-LOGICAL-c494t-cedd330866eecdcaa76228544a031e20acf8b015cf7b6267cc5c021b4daaedb13 |
IEDL.DBID | AIKHN |
ISSN | 0196-6553 |
IngestDate | Sat Jul 26 06:31:18 EDT 2025 Mon Jul 21 10:17:27 EDT 2025 Mon Jul 21 06:03:34 EDT 2025 Thu Apr 24 23:10:54 EDT 2025 Tue Jul 01 01:59:08 EDT 2025 Fri Feb 23 02:29:53 EST 2024 Sun Feb 23 10:19:18 EST 2025 Tue Aug 26 19:31:39 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c494t-cedd330866eecdcaa76228544a031e20acf8b015cf7b6267cc5c021b4daaedb13 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ORCID | 0000-0002-4974-5607 |
PMID | 17765558 |
PQID | 68225855 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | hal_primary_oai_HAL_hal_00690447v1 proquest_miscellaneous_68225855 pubmed_primary_17765558 crossref_primary_10_1016_j_ajic_2007_02_006 crossref_citationtrail_10_1016_j_ajic_2007_02_006 elsevier_sciencedirect_doi_10_1016_j_ajic_2007_02_006 elsevier_clinicalkeyesjournals_1_s2_0_S0196655307004695 elsevier_clinicalkey_doi_10_1016_j_ajic_2007_02_006 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-09-01 |
PublicationDateYYYYMMDD | 2007-09-01 |
PublicationDate_xml | – month: 09 year: 2007 text: 2007-09-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of infection control |
PublicationTitleAlternate | Am J Infect Control |
PublicationYear | 2007 |
Publisher | Mosby, Inc Elsevier |
Publisher_xml | – name: Mosby, Inc – name: Elsevier |
References | Cornet, Levy, Fleury, Lortholary, Barguins, Coureul (bib8) 1999; 20 Price, Simmons, Crow, Ahearn (bib15) 2005; 32 Sherertz, Belani, Kramer, Elfenbein, Weiner, Sullivan (bib7) 1987; 83 Centers for Disease Control and Prevention (bib1) 1997; 46 Alberti, Bouakline, Ribaud, Lacroix, Rousselot, Leblanc (bib2) 2001; 48 Health Canada (bib3) 2001; 27 Uduman, Farrukh, Nath, Zuhair, Ifrahf, Khawla (bib13) 2002; 52 Carter, Barr (bib4) 1997; 18 Loo, Bertrand, Dixon, Vitye, DeSalis, McLean (bib5) 1996; 17 Simmons, Price, Noble, Crow, Ahearn (bib16) 1997; 58 Moritz, Peters, Nipko, Ruden (bib17) 2001; 203 Griffiths, Bennett, Speight, Parks (bib14) 2005; 61 Kumari, Haji, Keer, Hawkey, Duncanson, Flower (bib11) 1998; 39 Gangneux, Bretagne, Cordonnier, Datry, Derouin, Grillot (bib18) 2002; 35 Munoz, Guinea, Pelaez, Duran, Blanco, Bouza (bib10) 2004; 6 Weems, Davis, Tablan, Kaufman, Martone (bib6) 1987; 8 McDonald, Walker, Carson, Arduino, Aguero, Gomez (bib12) 1998; 17 Lutz, Jin, Rinaldi, Wickes, Huycke (bib9) 2003; 37 Centers for Disease Control and Prevention (10.1016/j.ajic.2007.02.006_bib1) 1997; 46 Health Canada (10.1016/j.ajic.2007.02.006_bib3) 2001; 27 Cornet (10.1016/j.ajic.2007.02.006_bib8) 1999; 20 Carter (10.1016/j.ajic.2007.02.006_bib4) 1997; 18 Simmons (10.1016/j.ajic.2007.02.006_bib16) 1997; 58 Griffiths (10.1016/j.ajic.2007.02.006_bib14) 2005; 61 Kumari (10.1016/j.ajic.2007.02.006_bib11) 1998; 39 Gangneux (10.1016/j.ajic.2007.02.006_bib18) 2002; 35 Munoz (10.1016/j.ajic.2007.02.006_bib10) 2004; 6 Moritz (10.1016/j.ajic.2007.02.006_bib17) 2001; 203 Weems (10.1016/j.ajic.2007.02.006_bib6) 1987; 8 Price (10.1016/j.ajic.2007.02.006_bib15) 2005; 32 Lutz (10.1016/j.ajic.2007.02.006_bib9) 2003; 37 McDonald (10.1016/j.ajic.2007.02.006_bib12) 1998; 17 Uduman (10.1016/j.ajic.2007.02.006_bib13) 2002; 52 Loo (10.1016/j.ajic.2007.02.006_bib5) 1996; 17 Sherertz (10.1016/j.ajic.2007.02.006_bib7) 1987; 83 Alberti (10.1016/j.ajic.2007.02.006_bib2) 2001; 48 |
References_xml | – volume: 32 start-page: 319 year: 2005 end-page: 321 ident: bib15 article-title: Mold colonization during use of preservative-treated and untreated air filters, including HEPA filters from hospitals and commercial locations over an 8-year period (1996-2003) publication-title: J Ind Micobiol Biotechnol – volume: 17 start-page: 716 year: 1998 end-page: 722 ident: bib12 article-title: Outbreak of publication-title: Pediatr Infect Dis J – volume: 52 start-page: 175 year: 2002 end-page: 180 ident: bib13 article-title: An Outbreak of publication-title: J Hosp Infect – volume: 35 start-page: 343 year: 2002 end-page: 346 ident: bib18 article-title: Prevention of nosocomial fungal infection: the French approach publication-title: Clin Infect Dis – volume: 46 start-page: 1 year: 1997 end-page: 79 ident: bib1 article-title: Guidelines for prevention of nosocomial pneumonia publication-title: MMWR – volume: 48 start-page: 198 year: 2001 end-page: 206 ident: bib2 article-title: Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients publication-title: J Hosp Infect – volume: 20 start-page: 508 year: 1999 end-page: 513 ident: bib8 article-title: Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against publication-title: Infect Control Hosp Epidemiol – volume: 83 start-page: 709 year: 1987 end-page: 718 ident: bib7 article-title: Impact of air filtration on nosocomial publication-title: Am J Med – volume: 203 start-page: 401 year: 2001 end-page: 409 ident: bib17 article-title: Capability of air filters to retain airborne bacteria and molds in heating, ventilating and air-conditioning (HVAC) systems publication-title: Int Hyg Environ Health – volume: 17 start-page: 360 year: 1996 end-page: 364 ident: bib5 article-title: Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit publication-title: Infect Control Hosp Epidemiol – volume: 37 start-page: 786 year: 2003 end-page: 793 ident: bib9 article-title: Outbreak of invasive publication-title: Clin Infect Dis – volume: 61 start-page: 242 year: 2005 end-page: 247 ident: bib14 article-title: Determining the performance of a commercial air purification system for reducing airborne contamination using model micro-organisms: a new test methodology publication-title: J Hosp Infect – volume: 58 start-page: 900 year: 1997 end-page: 904 ident: bib16 article-title: Fungal colonization of air filters from hospitals publication-title: AIHA J – volume: 18 start-page: 587 year: 1997 end-page: 596 ident: bib4 article-title: Infection control issues in construction and renovation publication-title: Infect Control Hosp Epidemiol – volume: 8 start-page: 71 year: 1987 end-page: 75 ident: bib6 article-title: Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy publication-title: Infect Control – volume: 6 start-page: 50 year: 2004 end-page: 54 ident: bib10 article-title: Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system publication-title: Transpl Infect Dis – volume: 39 start-page: 127 year: 1998 end-page: 133 ident: bib11 article-title: Ventilation grilles as a potential source of methicillin-resistant publication-title: J Hosp Infect – volume: 27 start-page: 1 year: 2001 end-page: 46 ident: bib3 article-title: Construction-related nosocomial infections in patients in healthcare facilities: decreasing the risk of publication-title: Can Commun Dis Rep – volume: 18 start-page: 587 year: 1997 ident: 10.1016/j.ajic.2007.02.006_bib4 article-title: Infection control issues in construction and renovation publication-title: Infect Control Hosp Epidemiol doi: 10.1086/647679 – volume: 17 start-page: 360 year: 1996 ident: 10.1016/j.ajic.2007.02.006_bib5 article-title: Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit publication-title: Infect Control Hosp Epidemiol doi: 10.1086/647317 – volume: 37 start-page: 786 year: 2003 ident: 10.1016/j.ajic.2007.02.006_bib9 article-title: Outbreak of invasive Aspergillus infection in surgical patients, associated with a contaminated air-handling system publication-title: Clin Infect Dis doi: 10.1086/377537 – volume: 20 start-page: 508 year: 1999 ident: 10.1016/j.ajic.2007.02.006_bib8 article-title: Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation publication-title: Infect Control Hosp Epidemiol doi: 10.1086/501661 – volume: 35 start-page: 343 year: 2002 ident: 10.1016/j.ajic.2007.02.006_bib18 article-title: Prevention of nosocomial fungal infection: the French approach publication-title: Clin Infect Dis doi: 10.1086/341318 – volume: 27 start-page: 1 issue: Suppl 2 year: 2001 ident: 10.1016/j.ajic.2007.02.006_bib3 article-title: Construction-related nosocomial infections in patients in healthcare facilities: decreasing the risk of Aspergillus, Legionella and other infections publication-title: Can Commun Dis Rep – volume: 17 start-page: 716 year: 1998 ident: 10.1016/j.ajic.2007.02.006_bib12 article-title: Outbreak of Acinetobacter spp. Bloodstream infections in a nursery associated with contaminated aerosols and air conditioners publication-title: Pediatr Infect Dis J doi: 10.1097/00006454-199808000-00011 – volume: 203 start-page: 401 year: 2001 ident: 10.1016/j.ajic.2007.02.006_bib17 article-title: Capability of air filters to retain airborne bacteria and molds in heating, ventilating and air-conditioning (HVAC) systems publication-title: Int Hyg Environ Health doi: 10.1078/1438-4639-00054 – volume: 48 start-page: 198 year: 2001 ident: 10.1016/j.ajic.2007.02.006_bib2 article-title: Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients publication-title: J Hosp Infect doi: 10.1053/jhin.2001.0998 – volume: 52 start-page: 175 year: 2002 ident: 10.1016/j.ajic.2007.02.006_bib13 article-title: An Outbreak of Serratia marcescens infection in a special-care baby unit of a community hospital in United Arab Emirates: the importance of the air conditioner duct as a nosocomial reservoir publication-title: J Hosp Infect doi: 10.1053/jhin.2002.1308 – volume: 8 start-page: 71 year: 1987 ident: 10.1016/j.ajic.2007.02.006_bib6 article-title: Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy publication-title: Infect Control doi: 10.1017/S0195941700067114 – volume: 83 start-page: 709 year: 1987 ident: 10.1016/j.ajic.2007.02.006_bib7 article-title: Impact of air filtration on nosocomial Aspergillus infections: unique risk of bone marrow transplant recipients publication-title: Am J Med doi: 10.1016/0002-9343(87)90902-8 – volume: 6 start-page: 50 year: 2004 ident: 10.1016/j.ajic.2007.02.006_bib10 article-title: Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system publication-title: Transpl Infect Dis doi: 10.1111/j.1399-3062.2004.00047.x – volume: 58 start-page: 900 year: 1997 ident: 10.1016/j.ajic.2007.02.006_bib16 article-title: Fungal colonization of air filters from hospitals publication-title: AIHA J doi: 10.1080/15428119791012252 – volume: 61 start-page: 242 year: 2005 ident: 10.1016/j.ajic.2007.02.006_bib14 article-title: Determining the performance of a commercial air purification system for reducing airborne contamination using model micro-organisms: a new test methodology publication-title: J Hosp Infect doi: 10.1016/j.jhin.2005.03.004 – volume: 46 start-page: 1 year: 1997 ident: 10.1016/j.ajic.2007.02.006_bib1 article-title: Guidelines for prevention of nosocomial pneumonia publication-title: MMWR – volume: 39 start-page: 127 year: 1998 ident: 10.1016/j.ajic.2007.02.006_bib11 article-title: Ventilation grilles as a potential source of methicillin-resistant Staphylococcus aureus causing an outbreak in an orthopaedic ward at a district general hospital publication-title: J Hosp Infect doi: 10.1016/S0195-6701(98)90326-7 – volume: 32 start-page: 319 year: 2005 ident: 10.1016/j.ajic.2007.02.006_bib15 article-title: Mold colonization during use of preservative-treated and untreated air filters, including HEPA filters from hospitals and commercial locations over an 8-year period (1996-2003) publication-title: J Ind Micobiol Biotechnol doi: 10.1007/s10295-005-0226-1 |
SSID | ssj0009365 |
Score | 1.9003056 |
Snippet | Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats... Background Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne... BACKGROUND: Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne... |
SourceID | hal proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 460 |
SubjectTerms | Air Microbiology Air Pollution, Indoor Air Pollution, Indoor - prevention & control Aspergillosis Aspergillosis - microbiology Aspergillosis - prevention & control Aspergillus Aspergillus - isolation & purification Child Child, Preschool Colony Count, Microbial Decontamination Decontamination - instrumentation Environment, Controlled Equipment Design France Fungi Fungi - isolation & purification Hospitals, Pediatric Humans Immunocompromised Host Infection Control Infection Control - instrumentation Infectious Disease Life Sciences Microbiology and Parasitology Mycoses Mycoses - prevention & control |
Title | Evaluation of a new mobile system for protecting immune-suppressed patients against airborne contamination |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0196655307004695 https://www.clinicalkey.es/playcontent/1-s2.0-S0196655307004695 https://dx.doi.org/10.1016/j.ajic.2007.02.006 https://www.ncbi.nlm.nih.gov/pubmed/17765558 https://www.proquest.com/docview/68225855 https://hal.science/hal-00690447 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELW67QUJVW35WkqLhbihsEns2MlxVbVaKPQClXqzJo5Ds6LZVbPLkd_OTOxshaBF4mpl8mHPjJ-dN8-MvY1rnUFdycgWWRxJyGOMucxGogAoMfupqh_pzxdqdik_XmVXW-xkqIUhWmXI_T6n99k6tExCb06WTTP5Qsouik690f0iLxuxnVQUCl17Z_rhfHZxp70rlGcyFioig1A742leMG8GJUOS7lT3zU-jayJK3odC-9nobI_tBhjJp_5N99mWaw_YY78Hx31p0RM2P91IefNFzYEjhOY3ixITAfcKzhwhKw9SDTiH8YaqRVzUrZc9P9ZVPOiudhy-QYNQkkNzi27TOk4kdyAiDd3_Kbs8O_16MovC2QqRlYVcRdi9lRC4nlHO2coCYFKkYkoJGOUujcHWeYlQwda6xDWPtjazCAdKWQG4qkzEM7bdLlr3gvE6zS2kZZ0Lp6WUWSFA54Djgq0S8cKYJUOPGhuEx-n8i-9mYJjNDY0CnYipTZyamGzebWyWXnbjwavFMFBmKCjFFGhwVnjQSv_NynUhijuTmA6vNH942phlG8vfnPWfT3yDXrT5IFL2nk0_GWrrFaOl1D-SMXs9OJnBUKf_N9C6xbozCsEcru7w8c-97911jdaKhNte_ueLHbJHfs-auHOv2Pbqdu2OEGytymM2ev8zOQ4h9Qsxiigo |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB615QASqnizfVqIGwqb3Th2cqyqVlvY9kIr9WZNHAeyguyq2eXIb2cmdrZCtEXiannysGfGn5NvPgO8jyudYlXKyOZpHEnMYoq51EZJjlhQ9lNlN9PnF2pyJT9dp9cbcNzXwjCtMuR-n9O7bB1ahmE0h4u6Hn5hZRfFp97obpOXbsIjSeHL0fnx1y3PI0-U5zHmKuLuoXLGk7xwVvc6hizcqe5bnTa_MU3yPgzarUWnz2A7gEhx5J_zOWy45gU89V_ghC8segmzk7WQt5hXAgUBaPFjXlAaEF6_WRBgFUGogVYwUXOtiIva1aJjx7pSBNXVVuBXrAlICqxvyGkaJ5jijkyj4eu_gqvTk8vjSRROVoiszOUyosEtk4R2M8o5W1pESolcSimRYtyNY7RVVhBQsJUuaMejrU0tgYFCloiuLEbJa9hq5o17C6IaZxbHRZUlTksp0zxBnSHNCrVKQgsDGPUjamyQHefTL76bnl82MzwLfB6mNvHYxGzzYW2z8KIbD_ZO-okyfTkpJUBDa8KDVvouK9eGGG7NyLTU0_zlZwNI15Z_uOo_7_iOvGj9QqzrPTmaGm7r9KKl1D9HAzjsncxQoPPfG2zcfNUaRVCO9nZ0-zfe926HRmvFsm07__lgh_B4cnk-NdOzi8-78MR_vWYW3R5sLW9Wbp9g17I46MLqN6CpKOw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+a+new+mobile+system+for+protecting+immune-suppressed+patients+against+airborne+contamination&rft.jtitle=American+journal+of+infection+control&rft.au=Poirot%2C+Jean-Louis%2C+MD&rft.au=Gangneux%2C+Jean-Pierre%2C+MD&rft.au=Fischer%2C+Alain%2C+MD%2C+PhD&rft.au=Malbernard%2C+Mireille%2C+RN&rft.date=2007-09-01&rft.issn=0196-6553&rft.volume=35&rft.issue=7&rft.spage=460&rft.epage=466&rft_id=info:doi/10.1016%2Fj.ajic.2007.02.006&rft.externalDBID=ECK1-s2.0-S0196655307004695&rft.externalDocID=1_s2_0_S0196655307004695 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01966553%2FS0196655307X01482%2Fcov150h.gif |